company background image
853

MicroPort Scientific SEHK:853 Stock Report

Last Price

HK$23.15

Market Cap

HK$42.0b

7D

27.1%

1Y

-67.2%

Updated

26 Jun, 2022

Data

Company Financials +
853 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

853 Stock Overview

MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People’s Republic of China, North America, Europe, other Asian countries, South America, and internationally.

MicroPort Scientific Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for MicroPort Scientific
Historical stock prices
Current Share PriceHK$23.15
52 Week HighHK$72.85
52 Week LowHK$12.24
Beta0.069
1 Month Change68.98%
3 Month Change31.39%
1 Year Change-67.23%
3 Year Change299.14%
5 Year Change276.42%
Change since IPO179.25%

Recent News & Updates

Jun 08
Is MicroPort Scientific (HKG:853) Weighed On By Its Debt Load?

Is MicroPort Scientific (HKG:853) Weighed On By Its Debt Load?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

853HK Medical EquipmentHK Market
7D27.1%15.3%2.1%
1Y-67.2%-60.3%-23.3%

Return vs Industry: 853 underperformed the Hong Kong Medical Equipment industry which returned -60.3% over the past year.

Return vs Market: 853 underperformed the Hong Kong Market which returned -23.3% over the past year.

Price Volatility

Is 853's price volatile compared to industry and market?
853 volatility
853 Average Weekly Movement11.2%
Medical Equipment Industry Average Movement9.1%
Market Average Movement7.0%
10% most volatile stocks in HK Market13.8%
10% least volatile stocks in HK Market3.3%

Stable Share Price: 853 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: 853's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
19988,019Maxwell Changhttps://www.microport.com

MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People’s Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company’s Cardiovascular Devices segment offers products and services for the treatment of coronary artery-related diseases; coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma, and other professional implants and instruments.

MicroPort Scientific Fundamentals Summary

How do MicroPort Scientific's earnings and revenue compare to its market cap?
853 fundamental statistics
Market CapUS$5.36b
Earnings (TTM)-US$276.48m
Revenue (TTM)US$778.64m

6.9x

P/S Ratio

-19.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
853 income statement (TTM)
RevenueUS$778.64m
Cost of RevenueUS$286.87m
Gross ProfitUS$491.77m
Other ExpensesUS$768.26m
Earnings-US$276.48m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.15
Gross Margin63.16%
Net Profit Margin-35.51%
Debt/Equity Ratio46.2%

How did 853 perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is 853 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 853?

Other financial metrics that can be useful for relative valuation.

853 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue7.1x
Enterprise Value/EBITDA-21.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does 853's PS Ratio compare to its peers?

853 PS Ratio vs Peers
The above table shows the PS ratio for 853 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average3414.8x

Price-To-Sales vs Peers: 853 is good value based on its Price-To-Sales Ratio (6.9x) compared to the peer average (3414.8x).


Price to Earnings Ratio vs Industry

How does 853's PE Ratio compare vs other companies in the Hong Kong Medical Equipment Industry?

Price-To-Sales vs Industry: 853 is expensive based on its Price-To-Sales Ratio (6.9x) compared to the Hong Kong Medical Equipment industry average (6.2x)


Price to Sales Ratio vs Fair Ratio

What is 853's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

853 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.9x
Fair PS Ratio7.6x

Price-To-Sales vs Fair Ratio: 853 is good value based on its Price-To-Sales Ratio (6.9x) compared to the estimated Fair Price-To-Sales Ratio (7.6x).


Share Price vs Fair Value

What is the Fair Price of 853 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 853's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 853's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 853's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is MicroPort Scientific forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


18.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 853 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 853 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 853 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 853's revenue (19.4% per year) is forecast to grow faster than the Hong Kong market (10.3% per year).

High Growth Revenue: 853's revenue (19.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 853 is forecast to be unprofitable in 3 years.


Discover growth companies

Past Performance

How has MicroPort Scientific performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-69.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 853 is currently unprofitable.

Growing Profit Margin: 853 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 853 is unprofitable, and losses have increased over the past 5 years at a rate of 69.9% per year.

Accelerating Growth: Unable to compare 853's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 853 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (35.4%).


Return on Equity

High ROE: 853 has a negative Return on Equity (-15.84%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is MicroPort Scientific's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: 853's short term assets ($2.4B) exceed its short term liabilities ($546.8M).

Long Term Liabilities: 853's short term assets ($2.4B) exceed its long term liabilities ($1.6B).


Debt to Equity History and Analysis

Debt Level: 853 has more cash than its total debt.

Reducing Debt: 853's debt to equity ratio has reduced from 83.1% to 46.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 853 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 853 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Dividend

What is MicroPort Scientific current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 853's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 853's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 853's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 853's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: 853 is not paying a notable dividend for the Hong Kong market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 853 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

9.7yrs

Average management tenure


CEO

Maxwell Chang (58 yo)

24.42yrs

Tenure

US$49,135,000

Compensation

Dr. Zhaohua Chang,Ph D also known as Maxwell, serves as the Chief Executive Officer Shanghai MicroPort Medical (Group) Co., Ltd. He serves as the Chairman of MicroPort Scientific Corporation and serves as...


CEO Compensation Analysis

Compensation vs Market: Maxwell's total compensation ($USD49.14M) is above average for companies of similar size in the Hong Kong market ($USD626.60K).

Compensation vs Earnings: Maxwell's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: 853's management team is seasoned and experienced (9.7 years average tenure).


Board Members

Experienced Board: 853's board of directors are seasoned and experienced ( 11.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

MicroPort Scientific Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: MicroPort Scientific Corporation
  • Ticker: 853
  • Exchange: SEHK
  • Founded: 1998
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: HK$42.046b
  • Shares outstanding: 1.82b
  • Website: https://www.microport.com

Number of Employees


Location

  • MicroPort Scientific Corporation
  • 1601 Zhangdong Road
  • Zhangjiang Hi-Tech Park
  • Shanghai
  • 201203
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/26 00:00
End of Day Share Price2022/06/24 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.